Viibryd

Generic name: Vilazodone
Drug class: Miscellaneous antidepressants

Usage of Viibryd

Viibryd is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs).

Viibryd is used to treat major depressive disorder (MDD).

It is not known if Viibryd is safe and effective for use in children for the treatment of MDD.

Viibryd side effects

Get emergency medical help if you have signs of an allergic reaction to Viibryd: skin rash or hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.

Call your doctor at once if you have:

a seizure (convulsions);

blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;

easy bruising, unusual bleeding;

racing thoughts, unusual risk-taking behavior, decreased inhibitions, feelings of extreme happiness or sadness; or

low levels of sodium in the body - headache, confusion, slurred speech, severe weakness, loss of coordination, feeling unsteady.

Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

Common Viibryd side effects may include:

nausea, vomiting;

diarrhea; or

sleep problems (insomnia).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Viibryd

Do not use Viibryd if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, tranylcypromine, and others.

After you stop taking Viibryd, you must wait at least 14 days before you start taking an MAOI.

Tell your doctor if you also take stimulant medicine, opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. An interaction with Viibryd could cause a serious condition called serotonin syndrome.

To make sure Viibryd is safe for you, tell your doctor if you have: ever had:

liver or kidney disease;

a bleeding or blood clotting disorder;

narrow-angle glaucoma;

seizures or epilepsy;

bipolar disorder (manic depression);

sexual problems;

drug addiction or suicidal thoughts; or

if you drink alcohol.

Some young people have thoughts about suicide when first taking an antidepressant. Your doctor should check your progress at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

Taking this medicine during pregnancy could harm the baby, but stopping the medicine may not be safe for you. Do not start or stop Viibryd without asking your doctor.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of vilazodone on the baby.

Ask a doctor if it is safe to breastfeed while using this medicine.

Not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Viibryd

Usual Adult Dose for Depression:

Initial dose: 10 mg orally once a day for 7 days, followed by 20 mg orally once a day for an additional 7 days Maintenance dose: 40 mg orally once a day Comment: This drug should be taken with food. Use: Treatment of major depressive disorder (MDD)

Warnings

Do not use Viibryd if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, phenelzine, tranylcypromine, and others, or if you have had a methylene blue injection. A dangerous drug interaction could occur.

Some young people (children and adults ages 24 and younger) have thoughts about suicide when first taking an antidepressant. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

Viibryd is not approved for use by anyone younger than 18 years old.

Do not stop using Viibryd without first asking your doctor.

What other drugs will affect Viibryd

Using Viibryd with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.

Tell your doctor about all your current medicines. Many drugs can ionteract with vilazodone, especially:

any other antidepressants;

mephenytoin;

St. John's wort;

tramadol;

a diuretic or "water pill";

medicine to treat anxiety, mood disorders, or mental illness such as schizophrenia;

a blood thinner - warfarin, Coumadin, Jantoven; or

migraine headache medicine - sumatriptan, Imitrex, Maxalt, Treximet, and others.

This list is not complete and many other drugs may affect vilazodone. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.